Search hospitals > Maryland > Towson
Chesapeake Urology Research Associates
Claim this profileTowson, Maryland 21204
Global Leader in Prostate Cancer
Conducts research for Cancer
Conducts research for Bladder Cancer
Conducts research for Tumors
Conducts research for Recurrence
34 reported clinical trials
2 medical researchers
Summary
Chesapeake Urology Research Associates is a medical facility located in Towson, Maryland. This center is recognized for care of Prostate Cancer, Cancer, Bladder Cancer, Tumors, Recurrence and other specialties. Chesapeake Urology Research Associates is involved with conducting 34 clinical trials across 22 conditions. There are 2 research doctors associated with this hospital, such as Ronald Tutrone, MD and Richard Levin, MD.Area of expertise
1Prostate Cancer
Global LeaderStage IV
PSA
ALT positive
2Cancer
Top PIs
Ronald Tutrone, MDChesapeake Urology Research Associates7 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
7 reported clinical trials
13 drugs studied
Richard Levin, MDChesapeake Urology Research Associates5 years of reported clinical research
Studies Prostate Cancer
2 reported clinical trials
2 drugs studied
Clinical Trials running at Chesapeake Urology Research Associates
Prostate Cancer
Allergy
ADT + Apalutamide
for Prostate Cancer
The purpose of the study is to determine if the intermittent use of androgen-deprivation therapy (ADT) in participants with metastatic castrate-sensitive prostate cancer (mCSPC) who reached a prostate-specific antigen (PSA) level \< 0.2 nanograms/millilitres (ng/mL) after 6 months of treatment with apalutamide and ADT combination therapy provides non-inferior radiographic progression-free survival (rPFS) and a reduced burden of hot flashes measured as 18-month percent change in severity adjusted hot flash score.
Recruiting2 awards Phase 37 criteria
Lu-177 Ludotadipep
for Prostate Cancer
This trial tests the safety and effectiveness of a radioactive drug called [177Lu]Ludotadipep. The drug works by delivering radiation directly to certain cells to treat the condition. Lutetium-177 (177Lu) has been widely used in targeted therapy, particularly in peptide receptor radionuclide therapy (PRRT) for treating neuroendocrine tumors.
Recruiting2 awards Phase 1 & 2
ONC-392 + Lutetium
for Prostate Cancer
In this Phase 2 study, mCRPC patients with PSMA positive scans who progressed on prior ARTA and up to 2 lines of taxanes, and are naïve to lutetium Lu 177 vipivotide tetraxetan, will be enrolled. The study is open-label, randomized with active control, multi-center study.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Chesapeake Urology Research Associates?
Chesapeake Urology Research Associates is a medical facility located in Towson, Maryland. This center is recognized for care of Prostate Cancer, Cancer, Bladder Cancer, Tumors, Recurrence and other specialties. Chesapeake Urology Research Associates is involved with conducting 34 clinical trials across 22 conditions. There are 2 research doctors associated with this hospital, such as Ronald Tutrone, MD and Richard Levin, MD.